Swiss National Bank Lowers Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Posted by Defense World Staff on Aug 24th, 2023

Swiss National Bank decreased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 10.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 196,368 shares of the company’s stock after selling 23,000 shares during the period. Swiss National Bank owned approximately 0.21% of Acadia Healthcare worth $14,188,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in ACHC. Point72 Hong Kong Ltd purchased a new stake in Acadia Healthcare during the first quarter valued at about $38,000. Quadrant Capital Group LLC grew its stake in shares of Acadia Healthcare by 61.6% during the fourth quarter. Quadrant Capital Group LLC now owns 522 shares of the company’s stock valued at $43,000 after buying an additional 199 shares during the last quarter. Belpointe Asset Management LLC bought a new position in shares of Acadia Healthcare during the fourth quarter valued at about $46,000. Ronald Blue Trust Inc. grew its stake in shares of Acadia Healthcare by 66.5% during the first quarter. Ronald Blue Trust Inc. now owns 1,014 shares of the company’s stock valued at $83,000 after buying an additional 405 shares during the last quarter. Finally, Neo Ivy Capital Management grew its stake in shares of Acadia Healthcare by 1,821.7% during the fourth quarter. Neo Ivy Capital Management now owns 1,326 shares of the company’s stock valued at $109,000 after buying an additional 1,257 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on ACHC shares. Royal Bank of Canada raised their price objective on Acadia Healthcare from $93.00 to $99.00 and gave the company an “outperform” rating in a research note on Monday, July 31st. Credit Suisse Group raised their price objective on Acadia Healthcare to $95.00 in a research note on Thursday, May 4th. Finally, StockNews.com started coverage on Acadia Healthcare in a research note on Thursday, August 17th. They issued a “hold” rating on the stock. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $89.11.

Read Our Latest Analysis on Acadia Healthcare

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $75.57 on Thursday. The stock’s 50 day simple moving average is $76.26 and its two-hundred day simple moving average is $74.08. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.34 and a current ratio of 1.34. The stock has a market cap of $6.97 billion, a price-to-earnings ratio of 25.53, a PEG ratio of 1.93 and a beta of 1.32. Acadia Healthcare Company, Inc. has a fifty-two week low of $66.87 and a fifty-two week high of $89.85.

Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its earnings results on Thursday, July 27th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.09. Acadia Healthcare had a net margin of 9.74% and a return on equity of 10.27%. The firm had revenue of $731.34 million during the quarter, compared to analyst estimates of $707.06 million. As a group, analysts expect that Acadia Healthcare Company, Inc. will post 3.37 earnings per share for the current fiscal year.

About Acadia Healthcare

(Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. It offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, eating disorder facilities, and outpatient clinics.